MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Less than 1 min.Read

Launch of the HiMax Plus Widebody™ Fixation System for Foot Fusions

CrossRoads® Extremity Systems Reports HiMax® Plus Offers Greater Stability and a Lower Profile Coupled with Market Leading Compression

CrossRoads® Extremity Systems, the global leader in Staple Compression Plates(SCP) and nitinol technology for the lower extremities, announced it has received FDA clearance and launched the HiMax® Plus Widebody Fixation System.

HiMax Plus is the only foot bone fusion system on the market to provide flush insertion, market-leading compression, and a wide bridge for enhanced stability. The features work in conjunction to provide improved implant performance with more efficiency in the operating room than alternative technologies. HiMax® Plus is CrossRoads’ latest addition to its Comprehensive Nitinol System.

Chad Hollis, VP of Research and Development and Co-Founder, stated “HiMax Plus shows our continued commitment to be the leader in the development of nitinol applications for the lower extremities. The HiMax family is born from years of fine-tuning and we believe the addition of HiMax Plus gives surgeons an enhanced nitinol implant that will be an optimal solution for all types of fusions.” CrossRoads will unveil this new system at the American College of Foot and Ankle Surgeons (ACFAS) Annual 2020 Meeting taking place in San Antonio, TX February 19th through February 22nd. CrossRoads will be exhibiting at booth #143.

SourceCrossRoads® Extremity Systems

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

0
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

0
Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

0
Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

0
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

0
“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330